Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BJCT-BIOJECT-needle less injection product -- Ignore unavailable to you. Want to Upgrade?

To: Michael C. Woodward who wrote (95)	12/24/1997 9:45:00 AM
From: geewiz	Read Replies (1) \| Respond to of 534

Michael, Thanks for your vote of confidence in BJCT. I have had BJCT on the accumulation status for several years and am impressed by your confidence! What immediate prospects for such appreciation do you see? My own feeling on the equity; it's not going to get another boost until we get ISO certification. No big dopper is going to commit to our pre-fill platform unless they can market it world-wide, and to do so requires ISO certification. I do not expect this until April 98 which would be BJCT's first quarter 99. When ISO is attained I believe there are several pre-fill contracts that will follow soon. Until that happens I think we are in a trading range of $0.75 - $1.50. I would caution anyone to temper their expectations for capital appreciation, especially in the current market climate. We will be very luck to have earnings before the millennium! Are you professionally engaged in the Medical equipment field? I am not and although I am confident I know the company inside out, have read all public available information, and have met several of the R&D staff and the management, I still follow the company's technology as a pedestrian. I would enjoy a discussion of the potential DNA vaccines will offer our product line. Does anybody on this thread follow other micro-cap medical supply companies? I would enjoy exchanges on such while we wait for the comming good news on BJCT. Two micros I follow from a distance are OREX and GSII. Like BJCT they both have disposible products for medical care. OREX, like BJCT has had management that amost took it to bankrupcy; new management last spring, very interesting patents. GSII a very interesting product line and extensive patents. The company has even patented surgical proceedures that involve its' products! I don't have poitions in these companies yet, I am still doing research, both have threads on SI. I like the medical disposible market for its' non-cyclic growth potential. Comments appreciated! Happy Chanukam and Merry Christmas to all!!!! art